surgumedВестник СурГУ. МедицинаVestnik SurGU. Meditsina2949-3447Сургутский государственный университет10.1234/10.34822/2304-9448-2019-4-74-78surgumed-259Research ArticleМЕДИКО-БИОЛОГИЧЕСКИЕ НАУКИ. ОБЗОР ЛИТЕРАТУРЫLIFE SCIENCES. REVIEWSПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ ПОЛИГЕННОГО ИНДЕКСА РИСКА (PRS) ДЛЯ ОЦЕНКИ РИСКА РАЗВИТИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫPROSPECTS OF APPLYING THE POLYGENIC RISK SCORES (PRS) TO ESTIMATE THE RISK OF BREAST CANCER DEVELOPMENThttps://orcid.org/0000-0001-6620-2770СмирноваН. В.SmirnovaN. V.

магистр

e-mail: smirnova10nv@gmail.com

Master of Science

e-mail: smirnova10nv@gmail.com

https://orcid.org/0000-0001-9768-8574ЕлмуратовА. У.ElmuratovA. U.

научный сотрудник

e-mail: artem@genotek.ru

Author ID в РИНЦ: 928632

Researcher

e-mail: artem@genotek.ru

RSCI ID: 928632

Московская государственная академия тонкой химической технологии им. М. В. ЛомоносоваРоссияMoscow State Academy of Fine Chemical Technology named after M. V. LomonosovRussian FederationНаучно-исследовательский институт биомедицинской химии имени В. Н. Ореховича, г. Москва; ООО «Генотек» », г. МоскваРоссияInstitute of Biomedical Chemistry, Moscow; Genotek LLC, MoscowRussian Federation20192312201904 (42)7478Copyright © Смирнова Н.В., Елмуратов А.У., 20192019Смирнова Н.В., Елмуратов А.У.Smirnova N.V., Elmuratov A.U.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.surgumed.ru/jour/article/view/259полногеномный поиск ассоциацийрак молочной железыполигенный индекс рискаgenome-wide association study (GWAS)breast cancerpolygenic risk scoreReferencesInternational Agency for Research on Cancer, Cancer Today, Pie chart. URL: http://gco.iarc.fr/today/ (дата обращения: 22.08.2019).International Agency for Research on Cancer, Cancer Today, Pie chart. URL: http://gco.iarc.fr/today/ (дата обращения: 22.08.2019).Bray F., Ferlay J., Soerjomataram I., Siegel R. L.,Torre L. A., Jemal A. GLOBOcAn Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer J Clin. 2018. № 68 (6). P. 394-424.Bray F., Ferlay J., Soerjomataram I., Siegel R. L.,Torre L. A., Jemal A. GLOBOcAn Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer J Clin. 2018. № 68 (6). P. 394-424.Anderson B.O.,Yip C. H., Smith R. A., Shyyan R., Sener S. F., Eniu A., Carlson R. W., Azavedo E., Harford J. Guideline Implementation for Breast Healthcare in Low-income and Middle-income Countries: Overview of the Breast Health Global Initiative Global Summit 2007 // Cancer. 2008. № 113. P 2221-2243.Anderson B.O.,Yip C. H., Smith R. A., Shyyan R., Sener S. F., Eniu A., Carlson R. W., Azavedo E., Harford J. Guideline Implementation for Breast Healthcare in Low-income and Middle-income Countries: Overview of the Breast Health Global Initiative Global Summit 2007 // Cancer. 2008. № 113. P 2221-2243.Hall P, Easton D. Breast Cancer Screening: Time to Target Women at Risk // Br. J. Cancer. 2013. № 108. P. 2202-2204.Hall P, Easton D. Breast Cancer Screening: Time to Target Women at Risk // Br. J. Cancer. 2013. № 108. P. 2202-2204.Costa M., Saldanha P Risk Reduction Strategies in Breast Cancer Prevention // Eur J Breast Health. 2017. No. 13. P 103-112.Costa M., Saldanha P Risk Reduction Strategies in Breast Cancer Prevention // Eur J Breast Health. 2017. No. 13. P 103-112.Michailidou K., Lindstrom S., Dennis J., Beesley J., Hui S., Kar S., Lemacon A., Soucy P, Glubb D., Rostamianfar A. et al. Association Analysis Identifies 65 New Breast Cancer Risk Loci // Nature. 2017. № 551. P. 92-94.Michailidou K., Lindstrom S., Dennis J., Beesley J., Hui S., Kar S., Lemacon A., Soucy P, Glubb D., Rostamianfar A. et al. Association Analysis Identifies 65 New Breast Cancer Risk Loci // Nature. 2017. № 551. P. 92-94.Milne R. L., Kuchenbaecker K. B., Michailidou K., Beesley J., Kar S., Lindstrom S., Hui S., Lemacon A., Soucy P, Dennis J. et al. Identification of Ten Variants Associated with Risk of Estrogen-Receptor-Negative Breast Cancer // Nat Genet. 2017. No. 49. P. 17671778.Milne R. L., Kuchenbaecker K. B., Michailidou K., Beesley J., Kar S., Lindstrom S., Hui S., Lemacon A., Soucy P, Dennis J. et al. Identification of Ten Variants Associated with Risk of Estrogen-Receptor-Negative Breast Cancer // Nat Genet. 2017. No. 49. P. 17671778.CORDIS, International Randomized Study Comparing Personalized, Risk-Stratified to Standard Breast Cancer Screening in Women Aged 40-70. URL: https://cordis.europa.eu/project/rcn/212694en.html (дата обращения: 22.08.2019).CORDIS, International Randomized Study Comparing Personalized, Risk-Stratified to Standard Breast Cancer Screening in Women Aged 40-70. URL: https://cordis.europa.eu/project/rcn/212694en.html (дата обращения: 22.08.2019).Burton H., chowdhury S., Dent T., Hall A., Pashayan N., Pharoah P. Public Health Implications from COGS and Potential for Risk Stratification and Screening // Nat Genet. 2013. № 45. P. 349-351.Burton H., chowdhury S., Dent T., Hall A., Pashayan N., Pharoah P. Public Health Implications from COGS and Potential for Risk Stratification and Screening // Nat Genet. 2013. № 45. P. 349-351.Pashayan N., Duffy S. W., Chowdhury S., Dent T., Burton H., Neal D. E., Easton D. F., Eeles R., Pharoah P. Polygenic Susceptibility to Prostate and Breast Cancer: Implications for Personalised Screening // Br J Cancer. 2011. № 104. P 1656-1663.Pashayan N., Duffy S. W., Chowdhury S., Dent T., Burton H., Neal D. E., Easton D. F., Eeles R., Pharoah P. Polygenic Susceptibility to Prostate and Breast Cancer: Implications for Personalised Screening // Br J Cancer. 2011. № 104. P 1656-1663.Holm J., Li J., Darabi H., Eklund M., Eriksson M., Humphreys K., Hall P, Czene K. Associations of Breast Cancer Risk Prediction Tools with Tumor Characteristics and Metastasis // J Clin Oncol. 2016. № 34. P. 251-258.Holm J., Li J., Darabi H., Eklund M., Eriksson M., Humphreys K., Hall P, Czene K. Associations of Breast Cancer Risk Prediction Tools with Tumor Characteristics and Metastasis // J Clin Oncol. 2016. № 34. P. 251-258.Li J., Holm J., Bergh J., Eriksson M., Darabi H., Lindstrom L. S., Tornberg S., Hall P, Czene, K. Breast Cancer Genetic Risk Profile is Differentially Associa with Interval and Screen-Detected Breast Cancers // Ann Oncol. 2015. No. 26. P. 517-522.Li J., Holm J., Bergh J., Eriksson M., Darabi H., Lindstrom L. S., Tornberg S., Hall P, Czene, K. Breast Cancer Genetic Risk Profile is Differentially Associa with Interval and Screen-Detected Breast Cancers // Ann Oncol. 2015. No. 26. P. 517-522.Mavaddat N. et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes // The American Journal of Human Genetics. 2019. No. 104. P. 21-34.Mavaddat N. et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes // The American Journal of Human Genetics. 2019. No. 104. P. 21-34.Kuchenbaecker K. B., McGuffog L., Barrowdale D., Lee A., Soucy P., Dennis J., Domchek S. M., Robson M., Spurdle A. B., Ramus S. J. et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers // J Natl Cancer Inst. 2017. Vol. 109, № 7.Kuchenbaecker K. B., McGuffog L., Barrowdale D., Lee A., Soucy P., Dennis J., Domchek S. M., Robson M., Spurdle A. B., Ramus S. J. et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers // J Natl Cancer Inst. 2017. Vol. 109, № 7.Martin A. R., Kanai M., KamataniY., OkadaY., Neale B. M., Daly M. J. Clinical Use of Current Polygenic Risk Scores may Exacerbate Health Disparities // Nature Genetics. 2019. № 51. P. 584-591.Martin A. R., Kanai M., KamataniY., OkadaY., Neale B. M., Daly M. J. Clinical Use of Current Polygenic Risk Scores may Exacerbate Health Disparities // Nature Genetics. 2019. № 51. P. 584-591.MyPeBS (My Personal Breast Screening). The Project. URL: https://mypebs.eu/the-project/ (дата обращения: 22.08.2019).MyPeBS (My Personal Breast Screening). The Project. URL: https://mypebs.eu/the-project/ (дата обращения: 22.08.2019).

The authors declare that there are no conflicts of interest present.